title: Bystander protein protects potential vaccine-targeting ligands against intestinal proteolysis.
abstract: Endowing mucosal vaccines with ligands that target antigen to mucosal lymphoid tissues may improve immunization efficacy provided that the ligands withstand the proteolytic environment of the gastro-intestinal tract until they reach their destination. Our aim was to investigate whether and how three renowned ligands - Ulex europaeus agglutinin I and the B subunits of cholera toxin and E. coli heat-labile enterotoxin - master this challenge. We assessed the digestive power of natural murine intestinal fluid (natIF) using assays for trypsin, chymotrypsin and pancreatic elastase along with a test for nonspecific proteolysis. The natIF was compared with simulated murine intestinal fluid (simIF) that resembled the trypsin, chymotrypsin and elastase activities of its natural counterpart but lacked or contained albumins as additional protease substrates. The ligands were exposed to the digestive fluids and degradation was determined. The studies revealed that (i) the three pancreatic endoproteases constitute only one third of the total protease activity of natIF and (ii) the ligands resist proteolysis in natIF and protein-enriched simIF over 3 h but (iii) are partially destroyed in simIF that lacks additional protease substrate. We assume that the proteins of natIF are preferred substrates for the intestinal proteases and thus can protect vaccine-targeting ligands from destruction.
authors.affiliation: Research Center Borstel, Division of Mucosal Immunology, Parkallee 1-40, 23845 Borstel, Germany.
authors.forename: Fabian
authors.initials: F
authors.lastname: Reuter
authors.forename: Steffen
authors.initials: S
authors.lastname: Bade
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Hirst
authors.forename: Andreas
authors.initials: A
authors.lastname: Frey